SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-19-001572
Filing Date
2019-08-09
Accepted
2019-08-09 16:56:24
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q embi_10q.htm 10-Q 581131
2 CERTIFICATION embi_ex311.htm EX-31.1 8090
3 CERTIFICATION embi_ex312.htm EX-31.2 8135
4 CERTIFICATION embi_ex321.htm EX-32.1 3003
5 CERTIFICATION embi_ex322.htm EX-32.2 2997
  Complete submission text file 0001640334-19-001572.txt   4365015

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT embi-20190630.xml EX-101.INS 829455
7 XBRL TAXONOMY EXTENSION SCHEMA embi-20190630.xsd EX-101.SCH 59564
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20190630_cal.xml EX-101.CAL 25552
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20190630_def.xml EX-101.DEF 273398
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20190630_lab.xml EX-101.LAB 440610
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20190630_pre.xml EX-101.PRE 355468
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 191013603
SIC: 2834 Pharmaceutical Preparations